Total Payments
$5,592
2024 Payments
$1,051
Companies
46
Transactions
336
Medicare Patients
2,885
Medicare Billing
$364,729
Payment Breakdown by Category
Food & Beverage$5,571 (99.6%)
Education$20.92 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,571 | 334 | 99.6% |
| Education | $20.92 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $855.27 | 52 | $0 (2024) |
| Novo Nordisk Inc | $836.01 | 55 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $651.81 | 40 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $331.54 | 20 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $317.49 | 16 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $283.82 | 22 | $0 (2022) |
| Amgen Inc. | $231.94 | 12 | $0 (2024) |
| Dexcom, Inc. | $178.39 | 5 | $0 (2024) |
| ABBVIE INC. | $159.49 | 10 | $0 (2024) |
| PFIZER INC. | $158.52 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,051 | 48 | Lilly USA, LLC ($186.59) |
| 2023 | $1,012 | 49 | Lilly USA, LLC ($212.92) |
| 2022 | $599.39 | 35 | Novo Nordisk Inc ($160.53) |
| 2021 | $252.16 | 15 | Novo Nordisk Inc ($52.68) |
| 2020 | $220.86 | 14 | Lilly USA, LLC ($46.24) |
| 2019 | $628.05 | 41 | AstraZeneca Pharmaceuticals LP ($200.84) |
| 2018 | $932.67 | 63 | Novo Nordisk Inc ($220.87) |
| 2017 | $895.62 | 71 | Lilly USA, LLC ($170.87) |
All Payment Transactions
336 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: Urology | ||||||
| 11/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Cardio-renal | ||||||
| 11/12/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $39.69 | General |
| Category: Endocrinology | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: VACCINES | ||||||
| 10/29/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $30.62 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/22/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Bone Health | ||||||
| 10/14/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: Oncology | ||||||
| 10/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/17/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Cardio-renal | ||||||
| 09/09/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Genetic Disease | ||||||
| 08/29/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $16.93 | General |
| Category: Medical Device | ||||||
| 08/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $13.21 | General |
| Category: GI | ||||||
| 08/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $39.57 | General |
| Category: Endocrinology | ||||||
| 08/13/2024 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Diabetes | ||||||
| 07/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: Diabetes | ||||||
| 07/16/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $36.16 | General |
| Category: Endocrinology | ||||||
| 07/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Diabetes | ||||||
| 07/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $1.60 | General |
| Category: Diabetes | ||||||
| 07/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 778 | 1,239 | $304,478 | $106,808 |
| 2022 | 9 | 591 | 997 | $222,268 | $74,453 |
| 2021 | 13 | 820 | 1,320 | $278,639 | $102,872 |
| 2020 | 10 | 696 | 1,216 | $263,781 | $80,596 |
Total Patients
2,885
Total Services
4,772
Medicare Billing
$364,729
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 240 | 690 | $170,430 | $55,187 | 32.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 69 | 69 | $54,786 | $19,207 | 35.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 129 | 129 | $32,766 | $15,808 | 48.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 77 | 79 | $11,376 | $5,590 | 49.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 25 | $9,100 | $2,777 | 30.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 79 | 81 | $6,480 | $2,314 | 35.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 72 | 72 | $5,760 | $2,025 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 27 | $4,428 | $1,197 | 27.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $4,444 | $1,062 | 23.9% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 18 | 20 | $1,200 | $771.40 | 64.3% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 18 | 18 | $2,250 | $694.26 | 30.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 18 | 18 | $1,458 | $174.88 | 12.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 237 | 634 | $156,594 | $46,828 | 29.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 101 | 101 | $25,650 | $12,322 | 48.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 72 | 74 | $10,656 | $4,915 | 46.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 23 | 25 | $9,099 | $3,361 | 36.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 77 | 79 | $6,320 | $2,121 | 33.6% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 12 | 13 | $5,837 | $2,055 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 33 | $5,412 | $1,735 | 32.1% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 17 | 17 | $1,020 | $618.80 | 60.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 21 | 21 | $1,680 | $498.18 | 29.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 266 | 752 | $176,720 | $58,264 | 33.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 147 | 147 | $35,427 | $18,791 | 53.0% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 80 | 80 | $10,960 | $4,943 | 45.1% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 17 | 22 | $9,394 | $3,493 | 37.2% |
About Dr. Lloyd Hepburn, MD
Dr. Lloyd Hepburn, MD is a Internal Medicine healthcare provider based in North Charleston, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770531972.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lloyd Hepburn, MD has received a total of $5,592 in payments from pharmaceutical and medical device companies, with $1,051 received in 2024. These payments were reported across 336 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($5,571).
As a Medicare-enrolled provider, Hepburn has provided services to 2,885 Medicare beneficiaries, totaling 4,772 services with total Medicare billing of $364,729. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location North Charleston, SC
- Active Since 05/04/2006
- Last Updated 06/28/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1770531972
Products in Payments
- FARXIGA (Drug) $493.90
- Ozempic (Drug) $347.92
- JARDIANCE (Drug) $334.39
- TRULICITY (Drug) $326.51
- Kerendia (Drug) $317.49
- MOUNJARO (Drug) $271.50
- TRADJENTA (Drug) $181.57
- Dexcom G6 Transmitter (Medical Supply) $178.39
- XARELTO (Drug) $168.42
- Cologuard Collection Kit (Device) $138.38
- Victoza (Drug) $130.05
- Rybelsus (Drug) $117.71
- INVOKANA (Drug) $109.38
- SYMBICORT (Drug) $99.10
- Tresiba (Drug) $99.00
- ENTRESTO (Drug) $97.23
- Mitigare (Drug) $89.53
- Linzess (Drug) $85.48
- UBRELVY (Drug) $76.55
- TOUJEO (Drug) $76.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in North Charleston
Dr. Jerry Back, Md, MD
Internal Medicine — Payments: $602,355
Internal Medicine $602,355
Dr. Darren Sidney, M.d, M.D
Internal Medicine — Payments: $177,289
Internal Medicine $177,289
Patrick Looser, M.d, M.D
Internal Medicine — Payments: $26,213
Internal Medicine $26,213
Jared Intaphan, M.d, M.D
Internal Medicine — Payments: $13,433
Internal Medicine $13,433
Dr. James Fitzpatrick, D. O, D. O
Internal Medicine — Payments: $4,385
Internal Medicine $4,385
Dr. Marabel Schneider, Md, MD
Internal Medicine — Payments: $4,141
Internal Medicine $4,141